VPHIF

Healthcare Drug Manufacturers - Specialty & Generic

Valeo Pharma Inc.

$0.00

+0.00 +0.00% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 9:47 AM ET	0.00

Key Stats

Market Cap

9,865.743

Avg Volume

EPS

-$0.27

52W High

$0.12

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

P/S Ratio

0.00

EV/EBITDA

-4.51

EV/Revenue

1.19

Margins

Gross Margin 22.5%

Operating Margin (9.7%)

Net Margin (60.2%)

EBITDA Margin (26.4%)

Growth & Returns

Revenue Growth (YoY)

(10.5%)

Return on Assets

(26.1%)

Liquidity & Leverage

Current Ratio

0.27

Quick Ratio

0.17

Total Cash

7.13M

Total Debt

70.73M

About

Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs. The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas. It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and commercialization through all stages. The company offers access to product specialists and medical information for healthcare professionals and patients. Valeo Pharma serves healthcare professionals, including Canadian physicians, and focuses on hospital specialty sectors. The company was founded in 2003 and is based in Kirkland, Canada.